88 related articles for article (PubMed ID: 8423538)
1. A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans.
Bickel WK; Oliveto AH; Kamien JB; Higgins ST; Hughes JR
J Pharmacol Exp Ther; 1993 Jan; 264(1):360-7. PubMed ID: 8423538
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
Stoops WW; Lile JA; Glaser PE; Rush CR
Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504
[TBL] [Abstract][Full Text] [Related]
3. Flumazenil discrimination by humans under a two-response and a novel-response procedure.
Smith BJ; Bickel WK
J Pharmacol Exp Ther; 1999 Dec; 291(3):1257-68. PubMed ID: 10565850
[TBL] [Abstract][Full Text] [Related]
4. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
Oliveto AH; Bickel WK; Hughes JR; Higgins ST; Badger G
Behav Pharmacol; 1997 Jun; 8(2-3):124-38. PubMed ID: 9833008
[TBL] [Abstract][Full Text] [Related]
5. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
[TBL] [Abstract][Full Text] [Related]
6. Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports.
Oliveto AH; Bickel WK; Hughes JR; Shea PJ; Higgins ST; Fenwick JW
J Pharmacol Exp Ther; 1992 Jun; 261(3):885-94. PubMed ID: 1602393
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus effects of benzodiazepine agonists and partial agonists in pentobarbital-trained rhesus monkeys.
Rowlett JK; Woolverton WL
Behav Pharmacol; 1998 Mar; 9(2):81-92. PubMed ID: 10065928
[TBL] [Abstract][Full Text] [Related]
8. Secobarbital in humans discriminating triazolam under two-response and novel-response procedures.
Kamien JB; Bickel WK; Smith BJ; Badger GJ; Hughes JR
Pharmacol Biochem Behav; 1997 Dec; 58(4):983-91. PubMed ID: 9408204
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans.
Oliveto AH; Rosen MI; Woods SW; Kosten TR
J Pharmacol Exp Ther; 1995 Jan; 272(1):231-41. PubMed ID: 7815337
[TBL] [Abstract][Full Text] [Related]
10. Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure.
Oliveto AH; Bickel WK; Kamien JB; Hughes JR; Higgins ST
Psychopharmacology (Berl); 1994 Apr; 114(3):417-23. PubMed ID: 7531852
[TBL] [Abstract][Full Text] [Related]
11. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
Rowlett JK; Woolverton WL
J Pharmacol Exp Ther; 1997 Jan; 280(1):162-73. PubMed ID: 8996194
[TBL] [Abstract][Full Text] [Related]
12. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure.
Oliveto AH; McCance-Katz E; Singha A; Hameedi F; Kosten TR
Behav Pharmacol; 1998 May; 9(3):207-17. PubMed ID: 9832935
[TBL] [Abstract][Full Text] [Related]
13. Discriminative-stimulus effects of triazolam in women and men.
Vansickel AR; Hays LR; Rush CR
Am J Drug Alcohol Abuse; 2006; 32(3):329-49. PubMed ID: 16864467
[TBL] [Abstract][Full Text] [Related]
14. The novel-response procedure in humans.
Smith BJ; Bickel WK
Pharmacol Biochem Behav; 1999 Oct; 64(2):245-50. PubMed ID: 10515298
[TBL] [Abstract][Full Text] [Related]
15. Triazolam discrimination by humans under a novel response procedure: effects of buspirone and lorazepam.
Kamien JB; Bickel WK; Oliveto AH; Smith BJ; Higgins ST; Hughes JR; Badger GJ
Behav Pharmacol; 1994 Jun; 5(3):315-325. PubMed ID: 11224281
[TBL] [Abstract][Full Text] [Related]
16. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
Rush CR; Kollins SH; Pazzaglia PJ
Exp Clin Psychopharmacol; 1998 Feb; 6(1):32-44. PubMed ID: 9526144
[TBL] [Abstract][Full Text] [Related]
17. Effects of the NMDA antagonist memantine on human methamphetamine discrimination.
Hart CL; Haney M; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2002 Dec; 164(4):376-84. PubMed ID: 12457267
[TBL] [Abstract][Full Text] [Related]
18. Effects of corticosterone and its synthesis blockade on the cocaine-induced discriminative stimulus effects in rats.
Filip M; Nowak E; Siwanowicz J; Przegaliński E
Pol J Pharmacol; 2000; 52(6):411-21. PubMed ID: 11334235
[TBL] [Abstract][Full Text] [Related]
19. Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo.
Smith BJ; Bickel WK
Drug Alcohol Depend; 2001 Feb; 61(3):249-60. PubMed ID: 11164689
[TBL] [Abstract][Full Text] [Related]
20. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
Lile JA; Stoops WW; Durell TM; Glaser PE; Rush CR
Exp Clin Psychopharmacol; 2006 May; 14(2):136-47. PubMed ID: 16756417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
